Biopharmaceutical regulatory pipeline complexity — the escalating global submission requirements, evolving FDA/EMA guidance documents, and specialized therapy area expertise demands representing the most resource-intensive challenge in drug development — creates the most commercially dynamic market segment, with the Healthcare Regulatory Affairs Outsourcing Market reflecting...